Conversion rate at two-month follow-up of smear-positive tuberculosis patients in Burkina Faso

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 12, 2007, Pages 1339-1344

  Dembele, Sary Mathurin ^a,e   Ouedraogo, H Z ^b   Combary, A ^a   Saleri, N ^c   Macq, J ^d   Dujardin, B ^d  

^a Programme National de Lutte Antituberculeuse   (Burkina Faso)

^b Public Health Research Institute for Health Sciences   (Burkina Faso)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^e Programme National Tuberculose   (Burkina Faso)

Author keywords

2 month follow up; Burkina Faso; Conversion; Smear positive; Tuberculosis

Indexed keywords

ARTICLE; BURKINA FASO; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FOLLOW UP; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SPUTUM EXAMINATION; SPUTUM SMEAR; TREATMENT FAILURE;

ANTITUBERCULAR AGENTS; BURKINA FASO; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 37648999878     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. World Health Organization. DOTS : un guide pour comprendre la stratégie DOTS contre la tuberculose recommandée par l'OMS. Geneva, Switzerland: WHO, 1999.
2. Enarson D, Rieder H, Arnadottir T, Trébucq A. Management of tuberculosis. A guide for low-income countries. 5th ed. Paris, France: International Union Against Tuberculosis and Lung Disease, 2000.
3. United Nations Development Programme. Human development report 2006. New York, USA: UNDP, 2006. http://www.undp.org Accessed 31 January 2007.
4. World Bank. Santé et pauvreté au Burkina Faso: progresser vers les objectifs nationaux dans le cadre de la stratégie de lutte contre la pauvreté. Ouagadougou, Burkina Faso: The World Bank/Région Afrique/Département du développement Humain/Série Documents de Travail, 2004.
5. Joint United Nations Programme on HIV/AIDS/World Health Organization. 2006 AIDS epidemic update. Geneva, Switzerland: UNAIDS, 2006: p 96.
6. Joint United Nations Programme on HIV/AIDS/Economic Commission for Africa. AIDS in Africa, country by country. Geneva, Switzerland: UNAIDS, 2000: p 243.
7. Measure DHS. Enquête Démographique et de Santé (EDSBFIII). Calverton, MD, USA: Demographic and Health Survey, ORC Macro, 2004.
8. World Health Organization. WHO report 2005. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2005.349. Geneva, Switzerland: WHO, 2005.
9. Organisation Mondiale de la Santé/Région de l'Afrique. Tuberculose et lutte antituberculeuse en Afrique de l'Ouest: bilan et perspectives. Info Tub 2003; 2: 2-8.
10. Programme National Tuberculose, Ministère de la Santé. Guide technique de lutte contre la tuberculose. Ouagadougou, Burkina Faso: Ministère de la Santé, 2005.
11. Trébucq A, Rieder H L. Two excellent tools for national tuberculosis programmes: history of previous treatment and sputum status at two months. Int J Tuberc Lung Dis 1998; 2: 184-186.
12. Harries A D, Gausi F, Salaniponi F M. When are follow-up sputum smears actually examined in patients treated for new smear-positive pulmonary tuberculosis? Int J Tuberc Lung Dis 2004; 8: 440-444.
13. Hounkpati A, Adjoh K, Massengo Kiamanga E M. Conversion at 2/3 months in tuberculosis patients of the Centre Antituberculeux of Lomé, Togo in 2002. Int J Tuberc Lung Dis 2005; 9 (Suppl): S174 [Abstract].
14. Rieder H L. Sputum smear conversion during directly observed treatment for tuberculosis. Tubercle Lung Dis 1996; 77: 124-129.
15. Singla R, Singla N, Sarin R, Arora V K. Influence of pre-treatment bacillary load on treatment outcome of pulmonary tuberculosis patients receiving DOTS under revised national tuberculosis control programme. Indian J Chest Dis Allied Sci 2005; 47: 19-23.
16. Kiliçaslan Z, Durmusoglu G, Tekdos D, Ates S. Conversion rates of smear and culture in pulmonary tuberculosis by self treatment and effective factors. Int J Tuberc Lung Dis 2002; 6 (Suppl): S119 [Abstract].
17. Randriamiharisoa H, Rakotoarisaonina A, Rasolovavalona T, et al. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment. Int J Tuberc Lung Dis 2002; 6: 909-912.
18. Zhao F Z, Levy M H. When sputum microscopy results at two and three months predict outcome of tuberculosis treatment. Int J Tuberc Lung Dis 1997; 1: 570-572.
19. Telzak E E, Fazal B A, Pollard C L, Turett G S, Justman J E, Blum S. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis 1997; 25: 666-670.
20. Bwire R, Borgdorff M W, Sticht-Groh V, et al. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. East Afr Med J 1999; 76: 307-313.
21. Dominguez-Castellano A, Muniain M A, Rodriguez-Bano J, et al. Factors associated with time to sputum smear conversion in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2003; 7: 432-438.
22. Visser M E, Texeira-Swiegelaar C, Maartens G. The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2004; 8: 260-262.
23. Cuevas L E, Almeyda L M, Mazunder P, et al. Effect of zinc on the tuberculin response of children exposed to adults with smear positive tuberculosis. Ann Trop Paediatr 2002; 22: 313-319.
24. Karyadi E, West C E, Schultink W, et al. A double blind, placebo controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. Am J Clin Nutr 2002; 75: 720-727.